Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00135421 · ClinicalTrials.gov registry record · Phase 1
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 271
- Enrollment target
NCT00135421: Completed Phase 1 study, sponsored by Bristol-Myers Squibb.
NCT00135421 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 271 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (352% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00135421, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 271 participants
- Enrollment target
Study Summary
The purpose of this clinical research study is to learn whether BMS-562086 is both safe and effective in treating outpatients with major depressive disorder.
Interventions
- DRUG Placebo
- DRUG Escitalopram
- DRUG Pexacerfont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 271 participants |
| Start Date | 2005-11 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
What the finished NCT00135421 record still lists
NCT00135421 is an interventional study that assigns participants to a tested intervention. The registered 271 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (352% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00135421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00135421 about?
NCT00135421 is a clinical study titled "Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder". The purpose of this clinical research study is to learn whether BMS-562086 is both safe and effective in treating outpatients with major depressive disorder.
What is the current status of trial NCT00135421?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 271 participants. The study started on 2005-11. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00135421?
The interventions under investigation include: Placebo (DRUG), Escitalopram (DRUG), Pexacerfont (DRUG).
Who is sponsoring clinical trial NCT00135421?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00135421's enrollment target sits among peer trials
271 150th of 2000 higher than 1,851 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03609216 · 271 participants · Phase 2
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
- NCT02468024 · 272 participants · Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- NCT05519449 · 272 participants · Phase 1
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- NCT06035939 · 272 participants · NA
SMYLS Multi-site Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia